A detailed history of Vanguard Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,242,993 shares of CLPT stock, worth $18.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,242,993
Previous 1,216,366 2.19%
Holding current value
$18.2 Million
Previous $6.56 Million 112.52%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.3 - $13.18 $141,123 - $350,943
26,627 Added 2.19%
1,242,993 $13.9 Million
Q2 2024

Aug 13, 2024

SELL
$5.25 - $6.73 $479,498 - $614,671
-91,333 Reduced 6.98%
1,216,366 $6.56 Million
Q1 2024

May 10, 2024

SELL
$6.03 - $7.86 $5,999 - $7,820
-995 Reduced 0.08%
1,307,699 $8.89 Million
Q4 2023

Feb 14, 2024

BUY
$4.46 - $7.07 $149,026 - $236,236
33,414 Added 2.62%
1,308,694 $8.89 Million
Q3 2023

Nov 14, 2023

BUY
$5.01 - $7.09 $279,477 - $395,508
55,784 Added 4.57%
1,275,280 $6.39 Million
Q2 2023

Aug 14, 2023

BUY
$6.54 - $10.58 $821,862 - $1.33 Million
125,667 Added 11.49%
1,219,496 $8.83 Million
Q1 2023

May 15, 2023

BUY
$7.33 - $10.63 $531,329 - $770,536
72,487 Added 7.1%
1,093,829 $9.23 Million
Q4 2022

Feb 10, 2023

BUY
$7.7 - $11.21 $257,749 - $375,243
33,474 Added 3.39%
1,021,342 $8.65 Million
Q3 2022

Nov 14, 2022

BUY
$9.82 - $16.49 $76,654 - $128,720
7,806 Added 0.8%
987,868 $10.2 Million
Q2 2022

Aug 12, 2022

SELL
$7.09 - $13.65 $713,211 - $1.37 Million
-100,594 Reduced 9.31%
980,062 $12.8 Million
Q1 2022

May 13, 2022

BUY
$7.8 - $11.6 $1.21 Million - $1.8 Million
154,867 Added 16.73%
1,080,656 $11.2 Million
Q4 2021

Feb 14, 2022

BUY
$11.08 - $18.86 $712,621 - $1.21 Million
64,316 Added 7.47%
925,789 $10.4 Million
Q3 2021

Nov 12, 2021

BUY
$16.58 - $22.25 $637,318 - $855,267
38,439 Added 4.67%
861,473 $15.3 Million
Q2 2021

Aug 13, 2021

BUY
$17.23 - $22.77 $14.2 Million - $18.7 Million
823,034 New
823,034 $15.7 Million

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $358M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.